Your Screen will Display your Personal Code like this
To ensure you receive your 5% discount click button link above
OR the direct browser link will display
https://snwbl.io/platinumled-therapy-lights/BPYLM7208
receive
5% OFF
All Light Panels!
PROMOTE CELLULAR HEALTH
IMPROVE CIRCULATION
-
Stimulates Body to produce ATP
-
Stimulates collagen production
-
Strengthens hair and improves skin elasticity
-
Promotes connective tissue health
-
Improves healing of scars and tissue repair
-
Dilates blood vessels for increased flow
-
Protects red blood cells and platelets
-
May stimulate the brain's pineal gland
IMPROVE RECOVERY
-
Accelerates muscle repair
-
Stimulates mitochondria and stem cells for faster recovery
SUPPORT IMMUNE SYSTEM
Your provider will Individualized your Treatment Plan
Red light therapy naturally stimulates your body’s own production of ATP (Adenosine Triphosphate), a key element in cellular regeneration.
REDUCE PAIN
-
Promotes healing to nervous system
-
Eases joint stiffness and soreness
-
Diminishes inflammation
-
Reduces muscle spasms and increases blood flow
REDUCE INFLAMMATION
-
Soothes sore muscles, joint pain, and arthritis
-
Eases symptoms associated with autoimmune diseases, spinal cord and traumatic brain injuries
Promising Preliminary Research
Research plays a crucial role in understanding and advancing the field of photobiomodulation light therapy. Through rigorous scientific investigation, research helps to uncover the mechanisms, efficacy, and safety of this therapeutic approach. It provides evidence-based insights into the specific applications, optimal parameters, and potential benefits of photobiomodulation, ultimately contributing to its recognition as a valuable treatment modality in various healthcare disciplines.
June 2021
Whole-organ transdermal photobiomodulation (PBM) of COVID-19: A 50-patient case study
The study highlights the potential of Photobiomodulation (PBM) as a therapeutic modality for the treatment of COVID-19 and related inflammatory diseases. PBM therapy, using nonionizing electromagnetic radiation, has shown benefits such as reduced tissue inflammation, improved circulation, decreased pain, and accelerated recovery. The study conducted on a non-randomized sample of COVID-19 patients demonstrated that PBM treatment resulted in full symptom recovery within three weeks for all 50 patients, with the majority recovering within four days. Acute symptoms, including improved breathing, reduced coughing, fever relief, sinus congestion alleviation, and eye inflammation reduction, were rapidly relieved with PBM therapy, typically requiring a single session.
The study suggests that PBM has the potential to be a non-pharmacological treatment option for COVID-19, offering advantages over pharmacological regimens without adverse side effects. Further research is needed to optimize treatment pro
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646787/pdf/JBIO-15-0.pdf
March 2021
Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial
This research paper explores the potential benefits of adjunctive Photobiomodulation Therapy (PBMT) in the treatment of COVID-19 pneumonia. The study highlights the cytokine storm and acute respiratory distress syndrome (ARDS) as initial hallmarks of COVID-19 and the need for effective treatment strategies. PBMT, also known as low-level laser therapy, uses non-ionizing, non-thermal light sources to reduce inflammation and stimulate healing. Experimental and animal models have shown that PBMT has anti-inflammatory effects and can modulate the immune response. The study conducted a small-scale clinical trial with a PBMT group and a control group and assessed patient outcomes using pulmonary severity indices.
The results showed that the PBMT group had significant improvements in pulmonary function, oxygenation, and chest X-ray findings compared to the control group. Additionally, none of the PBMT patients required ICU admission or mechanical ventilation, while 60% of the control group did. The study suggests that adjunctive PBMT may improve the clinical status of COVID-19 patients, reduce the need for ventilator support, and enhance the recovery process. Further research with larger sample sizes is recommended to confirm these findings and explore the potential of PBMT in COVID-19 treatment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989376/pdf/jir-14-965.pdf
Dec 2020
The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection
The research study discusses the potential use of Photobiomodulation Therapy (PBMT), also known as cold laser therapy or low-level laser therapy (LLLT), in the treatment of patients with severe acute respiratory distress syndrome (ARDS) associated with COVID-19. The study highlights the severity of the disease caused by the SARS-CoV-2 virus and the wide range of symptoms it can present, from mild respiratory symptoms to acute respiratory distress syndrome and multi-organ dysfunction. The mortality rate in patients with ARDS is high, emphasizing the need for effective treatment strategies. The study explores the anti-inflammatory effects of PBMT and its potential role in improving respiratory symptoms in COVID-19 patients by reviewing published studies in this field.
The authors explain that PBMT involves the use of visible and near-infrared light to stimulate cellular functions and promote tissue healing. It has been used in various medical applications, including reducing pain, inflammation, and accelerating tissue repair. The study highlights experimental studies demonstrating the potential of PBMT in reducing lung inflammation, fibrosis, pneumonia, and acute respiratory disorders. Additionally, the antimicrobial effects of monochromatic blue light are discussed, suggesting its potential use in reducing secondary bacterial infections associated with respiratory viral infections like SARS-CoV-2.
The study emphasizes the need for further research and clinical trials to establish the efficacy of PBMT in treating COVID-19 and reducing lung inflammation and pneumonia associated with the disease. While there have been a few case reports demonstrating positive outcomes with PBMT in COVID-19 patients, more comprehensive studies are necessary to validate its effectiveness and establish proper treatment protocols.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956025/pdf/jlms-11-S23.pdf